Thank you, Mr. Chairman, and through you to our witnesses.
I was most interested in hearing how the project through CREATE and the TRIUMF project are more complementary than in competition. Now I better understand that TRIUMF's focus is the medical community, whereas the multi-purpose reactor, yes, it can make isotopes—it was never intended to—and does it very well, but it also services the nuclear industry as well as material science. It was through that general science that we spun off a whole new industry, which is spinning off the different science we're seeing at TRIUMF, not only in aeronautics, but we've seen bubble technologies, all the jobs there, as well as the new materials that will give rise to the yet unanticipated jobs of the future.
There seems to be a tendency for people to be distracted by the unproven technologies like the MAPLEs. Have you seen this business model? You're talking more than just about a multi-purpose reactor from the CREATE standpoint. You're talking about an entire national laboratory with that as the first piece of the puzzle, so to speak. We did have the particle accelerator, but that was left by the wayside and would have complemented it. Have you seen the model in existence, and if so, can you tell us whether or not it's successful and how it's working?